Frankfurt - Delayed Quote EUR
SELLAS Life Sciences Group, Inc. (RXK3.F)
1.1500
-0.0260
(-2.21%)
As of 8:04:42 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-35,402
-35,402
-31,410
-23,809
-26,021
Investing Cash Flow
--
--
-5,500
-4,500
--
Financing Cash Flow
46,758
46,758
22,315
24,079
12,074
End Cash Position
13,986
13,986
2,630
17,225
21,455
Capital Expenditure
--
--
-5,500
-4,500
--
Issuance of Capital Stock
46,164
46,164
22,225
23,994
9,005
Free Cash Flow
-35,402
-35,402
-36,910
-28,309
-26,021
12/31/2021 - 4/14/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
603233.SS DaShenLin Pharmaceutical Group Co., Ltd.
17.46
+0.34%
1OT.F Ovid Therapeutics Inc.
0.2260
+15.31%
AXD2.F Heron Therapeutics, Inc.
1.9010
+1.39%
HTD.SG Corcept Therapeutics Inc
60.20
-2.53%
REGN34.SA Regeneron Pharmaceuticals, Inc.
55.72
0.00%
1VT.MU Viking Therapeutics Inc
22.46
+0.42%
REGN.VI Regeneron Pharmaceuticals, Inc.
515.20
-0.88%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
BVNRY Bavarian Nordic A/S
7.72
0.00%